| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/12/1997 | WO1997020639A1 Reversibly, non-covalent bound surface coating |
| 06/12/1997 | WO1997020575A1 Targeted adenovirus vectors |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997020470A1 Regulation of plant development and physiology through plasmodesmatal macromolecular transport of proteins and oligonucleotides |
| 06/12/1997 | WO1997020468A1 LIVE ATTENUATED VACCINES BASED ON cp45 HPIV-3 STRAIN AND METHOD TO ENSURE ATTENUATION IN SUCH VACCINES |
| 06/12/1997 | WO1997020463A1 Controlled gene product delivery from a regulatable retroviral vector |
| 06/12/1997 | WO1997015655A3 New artificial tissue, method for the production and the use thereof |
| 06/12/1997 | WO1997014805A3 Methods for production of recombinant plasmids |
| 06/12/1997 | WO1997012972A3 Regulated genes and uses thereof |
| 06/12/1997 | WO1997012963A3 A paf-acetylhydrolase and use in therapy |
| 06/12/1997 | WO1997012035A3 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 06/12/1997 | WO1997011169A3 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 06/12/1997 | WO1997001639A3 Selection of recombinant molecules |
| 06/12/1997 | DE19545320A1 Thermolabile Uracil-DNA-Glykosylase, Verfahren zu deren Herstellung und Verwendung zur Entfernung von Uracil aus DNA Thermo-labile uracil-DNA glycosylase, to processes for their preparation and use for the removal of uracil from DNA |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2404957A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2243508A1 Urogenital sinus derived growth factor nucleotide and amino acid sequences |
| 06/12/1997 | CA2239951A1 Method and compositions for monitoring dna binding molecules in living cells |
| 06/12/1997 | CA2239868A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 06/12/1997 | CA2239728A1 Live attenuated vaccines based on cp45 hpiv-3 strain and method to ensure attenuation in such vaccines |
| 06/12/1997 | CA2239686A1 Method of screening for enzyme activity |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239305A1 Constructs and methods for enhancing protein levels in photosynthetic organisms |
| 06/12/1997 | CA2239226A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2238981A1 Viral vectors |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2238399A1 Modification of starch synthesis in plants |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | CA2237494A1 Dna encoding phage abortive infection protein from lactococcus lactis, and method of use thereof |
| 06/12/1997 | CA2237181A1 Tissue factor - kunitz domain fusion proteins as factor viia inhibitors |
| 06/12/1997 | CA2236913A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/11/1997 | EP0778351A2 Method of analysis or assay for polynucleotides and analyzer or instrument for polynucleotides |
| 06/11/1997 | EP0778349A2 Gene construct and the use thereof |
| 06/11/1997 | EP0778348A1 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
| 06/11/1997 | EP0778347A2 ATP and nucleic acid-binding protein with putative helicase and ATPase characteristics |
| 06/11/1997 | EP0778346A2 Method for cloning and producing the Scal restriction endonuclease in E. coli |
| 06/11/1997 | EP0778345A2 Process for the preparation of dienone macrolides |
| 06/11/1997 | EP0778343A1 Apparatus for introducing biological substances or biologically active substances |
| 06/11/1997 | EP0778280A2 Tag reagent and assay method |
| 06/11/1997 | EP0777859A1 Methods and test kits for specific and sensitive diagnosing of periodontal diseases |
| 06/11/1997 | EP0777779A1 A method for desizing cellulose-containing fabric |
| 06/11/1997 | EP0777750A1 High throughput screening method for sequences or genetic alterations in nucleic acids |
| 06/11/1997 | EP0777749A2 Coupled amplification and ligation method |
| 06/11/1997 | EP0777748A1 Peptide librairies as a source of syngenes |
| 06/11/1997 | EP0777741A1 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777738A1 Condii toxoplasma p30 expression cassette |
| 06/11/1997 | EP0777737A1 Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein |
| 06/11/1997 | EP0777736A1 Functional modified hsv1-tk |
| 06/11/1997 | EP0777735A1 Genetic manipulation of plants to increase stored carbohydrates |
| 06/11/1997 | EP0777734A2 New polypetides having a toxic activity against insects of the dipter family |
| 06/11/1997 | EP0777733A1 Method of treating birds with avian myelomonocytic growth factor |
| 06/11/1997 | EP0777732A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 06/11/1997 | EP0777731A1 Cloning and regulation of an endothelial cell protein c/activated protein c receptor |
| 06/11/1997 | EP0777730A1 Dna vector for bone-specific gene expression |
| 06/11/1997 | EP0777729A1 5-lipoxygenase-activating protein ii |
| 06/11/1997 | EP0777728A1 Polycystic kidney disease 1 gene and uses thereof |
| 06/11/1997 | EP0777727A1 Purified herpes simplex virus protease and methods of purification |
| 06/11/1997 | EP0777726A1 Microbial transglutaminases, their production and use |
| 06/11/1997 | EP0777690A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| 06/11/1997 | EP0777687A1 Trefoil peptide dimer |
| 06/11/1997 | EP0777686A1 Trophic factors for central nervous system regeneration |
| 06/11/1997 | EP0777685A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777679A1 Delivery of nucleic acids |
| 06/11/1997 | EP0777677A1 Methods of identifying compounds useful for treating autoimmune diseases |
| 06/11/1997 | EP0777675A1 Solid support reagents for the synthesis of 3'-nitrogen containing polynucleotides |
| 06/11/1997 | EP0777499A1 Live vaccine for the treatment of tumour diseases |
| 06/11/1997 | EP0777498A1 Conjugates made of metal complexes and oligonucleotides |
| 06/11/1997 | EP0777497A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777412A1 FbLATE PROMOTER |
| 06/11/1997 | EP0544824B1 Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression |
| 06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
| 06/11/1997 | EP0394409B1 Macrophage-derived inflammatory mediator (mip-2) |
| 06/11/1997 | CN1151763A Method of detecting human cytochrome P4502D6 gene polymorphism |
| 06/11/1997 | CN1151762A Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein |
| 06/11/1997 | CN1151761A Fabric cleaning compsns. containing subtilisin BPN' variants |
| 06/11/1997 | CN1151760A Serum paraoxonase |
| 06/11/1997 | CN1151759A Antibodies which bind to insect jut proteins and their use |
| 06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
| 06/11/1997 | CN1151757A Fabric cleaning composition containing subtilisin BPN' variants |
| 06/11/1997 | CN1151437A Nucleic acid amplification using reversibly inactivated thermostable enzyme |
| 06/10/1997 | US5637785 Genetically modified plants having modulated flower development |
| 06/10/1997 | US5637687 Methods and compositions for isolating nucleic acids |
| 06/10/1997 | US5637686 Tata-binding protein associated factor, nucleic acids |
| 06/10/1997 | US5637685 Normalized cDNA libraries |
| 06/10/1997 | US5637682 Genetic engineering |
| 06/10/1997 | US5637573 Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions |
| 06/10/1997 | US5637569 Ganglioside analogs |
| 06/10/1997 | US5637567 Method for modifying, diagnosing, and screening for IGF-I sensitive cell barrier properties |
| 06/10/1997 | US5637504 Stable yeast 2 μm vector |
| 06/10/1997 | US5637503 Plasmids, their construction and their use in the manufacture of a plasminogen activator |
| 06/10/1997 | US5637495 Plasmids for production of human growth hormone or polypeptide analog thereof, hosts containing the plasmids, products manufactured thereby, and related methods |
| 06/10/1997 | US5637493 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 06/10/1997 | US5637492 Activatable fibrinolytic and anti-thrombotic proteins |
| 06/10/1997 | US5637491 Genetic engineering; culture product of penicillium |
| 06/10/1997 | US5637490 Cultivating a transformant which is a plasmid containing gene |